Items where authors include "Coates, LC"

Export as [feed] Atom [feed] RSS
Number of items: 81.

Article

Helliwell, PS, Coates, LC, Ransom, M orcid.org/0000-0003-4359-8287 et al. (6 more authors) (2023) The comparative performance of three screening questionnaires for psoriatic arthritis in a primary care surveillance study. Rheumatology. kead310. ISSN 1462-0324

Palominos, PE, Fernández-Ávila, DG, Coates, LC et al. (18 more authors) (2022) Management of Dactylitis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations. The Journal of Rheumatology, 49 (11). jrheum.220311. ISSN 0315-162X

Orbai, A-M, Coates, LC, Deodhar, A et al. (10 more authors) (2022) Meaningful Improvement in General Health Outcomes with Guselkumab Treatment for Psoriatic Arthritis: Patient-Reported Outcomes Measurement Information System-29 Results from a Phase 3 Study. The Patient: Patient Centered Outcomes Research, 15 (6). pp. 657-668. ISSN 1178-1653

Ovseiko, PV, Gossec, L, Andreoli, L et al. (21 more authors) (2022) Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task force. RMD Open, 8 (2). e002518. ISSN 2056-5933

Coates, LC, Soriano, ER, Corp, N et al. (42 more authors) (2022) Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. Nature Reviews Rheumatology, 18 (8). pp. 465-479. ISSN 1759-4790

Coates, LC, Garrood, T, Gullick, N et al. (8 more authors) (2022) Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC. Rheumatology. ISSN 1462-0324

Coates, LC, O'Dwyer, J orcid.org/0000-0002-7212-6089, Meads, D et al. (3 more authors) (2022) Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era. The Lancet Rheumatology, 4 (6). E390-E391. ISSN 2665-9913

Tucker, L, Allen, A, Chandler, D et al. (16 more authors) (2022) The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs. Rheumatology. ISSN 1462-0324

Tucker, L, Allen, A, Chandler, D et al. (16 more authors) (2022) Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs. Rheumatology. keac260. ISSN 1462-0324

Coates, LC, Tillett, W, D'Agostino, MA et al. (8 more authors) (2022) Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study. The Lancet Rheumatology, 4 (4). e262-e273. ISSN 2665-9913

Coates, LC, Baraliakos, X, Blanco, FJ et al. (17 more authors) (2021) The phenotype of axial spondyloarthritis: is it dependent on HLA‐B27 status? Arthritis Care & Research, 73 (6). pp. 856-860. ISSN 2151-464X

Ye, W, Hackett, S, Vandevelde, C et al. (3 more authors) (2020) Comparing the visual analogue scale (VAS) and the numerical rating scale (NRS) in patient reported outcomes in psoriatic arthritis. The Journal of Rheumatology. jrheum.200928. ISSN 0315-162X

Tillett, W, Allen, A, Tucker, L et al. (17 more authors) (2020) Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope. Rheumatology. keaa526. ISSN 1462-0324

Marzo-Ortega, H orcid.org/0000-0002-9683-3407, Tan, AL orcid.org/0000-0002-9158-7243, McGonagle, D et al. (6 more authors) (2020) BSR Spondyloarthritis Course, 27 February 2020. Spondyloarthritis: pathogenesis, diagnosis and management. Rheumatology Advances in Practice, 4 (2). rkaa043. ISSN 2514-1775

Helliwell, PS, Coates, LC orcid.org/0000-0002-4756-663X, Chew, NS et al. (7 more authors) (2020) Comparing Psoriatic Arthritis Low-field Magnetic Resonance Imaging, Ultrasound, and Clinical Outcomes: Data from the TICOPA Trial. Journal of Rheumatology, 47 (9). 181385. pp. 1338-1343. ISSN 0315-162X

Coates, LC, Merola, JF, Mease, PJ et al. (10 more authors) (2020) Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis. Rheumatology. keaa271. ISSN 1462-0324

De Marco, G orcid.org/0000-0003-2406-161X, Berekméri, A, Coates, LC et al. (12 more authors) (2020) Systematic literature review of non-topical treatments for early, untreated (systemic therapy naïve) psoriatic disease: a GRAPPA initiative. Rheumatology Advances in Practice. ISSN 2514-1775

Goel, N, Coates, LC orcid.org/0000-0002-4756-663X, De Marco, G orcid.org/0000-0003-2406-161X et al. (11 more authors) (2020) GRAPPA 2019 Project Report. The Journal of Rheumatology Supplement, 96. pp. 53-57. ISSN 0380-0903

Coates, LC orcid.org/0000-0002-4756-663X, Mahmood, F, Freeston, J orcid.org/0000-0003-0358-338X et al. (3 more authors) (2020) Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial. Rheumatology, 59 (4). kez369. pp. 807-810. ISSN 1462-0324

Coates, LC orcid.org/0000-0002-4756-663X, Wallman, JK, McGonagle, D et al. (9 more authors) (2019) Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies. Arthritis Research & Therapy, 21 (1). 266. ISSN 1478-6354

Helliwell, PS, Favier, G, Gladman, DD et al. (6 more authors) (2019) Best-practice Indicators in Psoriatic Disease Care. The Journal of Rheumatology Supplement, 95. pp. 38-45. ISSN 0380-0903

Goel, N, FitzGerald, O, Gladman, DD et al. (6 more authors) (2019) GRAPPA 2018 Project Report. The Journal of Rheumatology Supplement, 95. pp. 54-57. ISSN 0380-0903

Tucker, LJ, Coates, LC and Helliwell, PS (2019) Assessing Disease Activity in Psoriatic Arthritis: A Literature Review. Rheumatology and Therapy, 6 (1). pp. 23-32. ISSN 2198-6576

Coates, LC orcid.org/0000-0002-4756-663X, Lubrano, E, Perrotta, FM et al. (3 more authors) (2019) What Should Be the Primary Target of “Treat to Target” in Psoriatic Arthritis? Journal of Rheumatology, 46 (1). pp. 38-42. ISSN 0315-162X

Mease, P, Coates, LC, Helliwell, PS et al. (14 more authors) (2018) Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial. The Lancet, 392 (10162). pp. 2367-2377. ISSN 0140-6736

Coates, LC orcid.org/0000-0002-4756-663X, Orbai, A-M, Morita, A et al. (6 more authors) (2018) Achieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients’ health-related quality of life and productivity. BMC Rheumatology, 2 (1). 24. ISSN 2520-1026

Helliwell, P, Coates, LC, FitzGerald, O et al. (8 more authors) (2018) Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease. Arthritis Research and Therapy, 20. 242. ISSN 1478-6354

Coates, LC, Savage, LJ, Chinoy, H et al. (9 more authors) (2018) Assessment of two screening tools to identify psoriatic arthritis in patients with psoriasis. Journal of the European Academy of Dermatology and Venereology, 32 (9). pp. 1530-1534. ISSN 0926-9959

Coates, LC orcid.org/0000-0002-4756-663X, Conaghan, PG orcid.org/0000-0002-3478-5665, D’Agostino, MA et al. (9 more authors) (2018) Remission in psoriatic arthritis—where are we now? Rheumatology, 57 (8). pp. 1321-1331. ISSN 1462-0324

Coates, LC orcid.org/0000-0002-4756-663X, Tillett, W, Shaddick, G et al. (3 more authors) (2018) Value of the Routine Assessment of Patient Index Data 3 in Patients With Psoriatic Arthritis: Results From a Tight‐Control Clinical Trial and an Observational Cohort. Arthritis Care and Research, 70 (8). pp. 1198-1205. ISSN 2151-464X

O'Dwyer, JL orcid.org/0000-0002-7212-6089, Meads, DM orcid.org/0000-0003-1369-2483, Hulme, CT orcid.org/0000-0003-2077-0419 et al. (7 more authors) (2018) Cost‐Effectiveness of Tight Control of Inflammation in Early Psoriatic Arthritis: Economic Analysis of a Multicenter Randomized Controlled Trial. Arthritis Care and Research, 70 (3). pp. 462-468. ISSN 2151-464X

Coates, LC orcid.org/0000-0002-4756-663X, FitzGerald, O, Merola, JF et al. (23 more authors) (2018) Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis. Arthritis & Rheumatology, 70 (3). pp. 345-355. ISSN 2326-5191

Mahmood, F, Coates, LC and Helliwell, PS (2018) Current concepts and unmet needs in psoriatic arthritis. Clinical Rheumatology, 37 (2). pp. 297-305. ISSN 0770-3198

Smolen, JS, Schöls, M, Braun, J et al. (34 more authors) (2018) Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Annals of the Rheumatic Diseases, 77 (1). pp. 3-17. ISSN 0003-4967

Coates, LC, Mahmood, F, Emery, P et al. (2 more authors) (2017) The dynamics of response as measured by multiple composite outcome tools in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial. Annals of the Rheumatic Diseases, 76 (10). ISSN 0003-4967

Coates, LC orcid.org/0000-0002-4756-663X, Gossec, L, Smolen, JS et al. (5 more authors) (2017) New GRAPPA and EULAR recommendations for the management of psoriatic arthritis: process and challenges faced. Rheumatology, 56 (8). pp. 1251-1253. ISSN 1462-0324

De Marco, G, Helliwell, P, McGonagle, D et al. (4 more authors) (2017) The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes. BMC Musculoskeletal Disorders, 18. 303. ISSN 1471-2474

Helliwell, PS, FitzGerald, O, Coates, LC et al. (2 more authors) (2017) GRAPPA 2016 Project Report. The Journal of Rheumatology, 44 (5). pp. 706-710. ISSN 0315-162X

Jadon, DR, Gladman, DD, Mease, PJ et al. (19 more authors) (2017) Proceedings of the GRAPPA 2016 Retreat. The Journal of Rheumatology, 44 (5). pp. 668-673. ISSN 0315-162X

Coates, LC orcid.org/0000-0002-4756-663X, Savage, L, Waxman, R et al. (3 more authors) (2017) An educational leaflet improves response to invitation for screening for arthritis in patients with psoriasis in primary care, but only in practices in the most deprived areas. Clinical Rheumatology, 36 (3). pp. 719-723. ISSN 0770-3198

Coates, LC and Helliwell, PS (2017) Psoriatic arthritis: state of the art review. Clinical Medicine, 17 (1). pp. 65-70. ISSN 1470-2118

Coates, LC orcid.org/0000-0002-4756-663X, FitzGerald, O, Helliwell, PS et al. (1 more author) (2016) Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same? Seminars in Arthritis and Rheumatism, 46 (3). pp. 291-304. ISSN 0049-0172

Coates, LC orcid.org/0000-0002-4756-663X and Helliwell, PS (2016) L.C. Coates and P.S. Helliwell reply. The Journal of Rheumatology, 43 (9). p. 1766. ISSN 0315-162X

Coates, LC orcid.org/0000-0002-4756-663X, Savage, L, Waxman, R et al. (3 more authors) (2016) Comparison of screening questionnaires to identifypsoriatic arthritis in a primary-care population: across-sectional study. British Journal of Dermatology, 175 (3). pp. 542-548. ISSN 0007-0963

Mathew, AJ, Coates, LC orcid.org/0000-0002-4756-663X, Danda, D et al. (1 more author) (2016) Psoriatic arthritis: Lessons from imaging studies and implications for therapy. Expert Review of Clinical Immunology, 13 (2). pp. 133-142. ISSN 1744-666X

Coates, LC orcid.org/0000-0002-4756-663X, Murphy, R and Helliwell, PS (2016) New GRAPPA recommendations for the management of psoriasis and psoriatic arthritis: process, challenges and implementation. British Journal of Dermatology, 174 (6). pp. 1174-1178. ISSN 0007-0963

Mease, PJ, Helliwell, PS, Boehncke, W-H et al. (5 more authors) (2016) GRAPPA 2015 Research and Education Project Reports. The Journal of Rheumatology, 43 (5). pp. 979-985. ISSN 0315-162X

Coates, LC and Helliwell, P (2016) Methotrexate Efficacy in the Tight Control in Psoriatic Arthritis Study. Journal of Rheumatology, 43 (2). pp. 356-361. ISSN 0315-162X

Coates, LC and Helliwell, PS (2016) Psoriasis flare with corticosteroid use in psoriatic arthritis. British Journal of Dermatology, 174 (1). pp. 219-221. ISSN 0007-0963

Coates, LC orcid.org/0000-0002-4756-663X, Moverley, AR, McParland, L et al. (7 more authors) (2015) Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised, controlled trial. The Lancet, 386 (10012). pp. 2489-2498. ISSN 0140-6736

Coates, LC orcid.org/0000-0002-4756-663X, Aslam, T, Al Balushi, F et al. (21 more authors) (2013) Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study). British Journal of Dermatology, 168 (4). pp. 802-807. ISSN 0007-0963

Coates, LC, Navarro-Coy, N, Brown, SR et al. (11 more authors) (2013) The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis. BMC Musculoskeletal Disorders, 14. 101. ISSN 1471-2474

Bowes, J, Ho, P, Flynn, E et al. (14 more authors) (2012) Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort. Annals of the Rheumatic Diseases, 71 (8). pp. 1350-1354. ISSN 0003-4967

Bennett, AN, McGonagle, D, O'Connor, P et al. (5 more authors) (2008) Severity of baseline magnetic resonance imaging–evident sacroiliitis and HLA–B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis & Rheumatism, 58 (11). pp. 3413-3418. ISSN 0004-3591

Conference or Workshop Item

Tillett, W, Day, J, Mchugh, N et al. (3 more authors) (2021) Continuous Composite Measures for Routine Care in Psoriatic Arthritis: Thresholds of Meaning and Clinically Important Difference Estimates for the 3 and 4 VAS Scales from a UK Multicentre Study. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Mease, PJ, Coates, LC, Van den Bosch, F et al. (8 more authors) (2021) Correlation Between Skin Involvement, Joint Involvement and Enthesitis in Patients with Active Psoriatic Arthritis: Post-hoc Analysis of EQUATOR/EQUATOR2. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Helliwell, P orcid.org/0000-0002-4155-9105, Coates, LC, Van den Bosch, F et al. (7 more authors) (2021) The Effect of Filgotinib on Enthesitis: 100-Week Data from an Open-Label Extension Study in Patients with Active Psoriatic Arthritis. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Coates, LC, Mease, PJ, Helliwell, P orcid.org/0000-0002-4155-9105 et al. (8 more authors) (2021) Effect of Filgotinib on Pasdas: Drivers of Low and Very Low Activity up to Week 100. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Coates, LC, Soriano, E, Corp, N et al. (31 more authors) (2021) The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Treatment Recommendations 2021. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Coates, LC, Ritchlin, CT, Gossec, L et al. (12 more authors) (2021) Guselkumab Provides Sustained Domain-Specific and Comprehensive Efficacy as Assessed using Composite Endpoints in Patients with Active Psoriatic Arthritis. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Orbai, AM, Coates, LC, Deodhar, A et al. (9 more authors) (2021) Guselkumab-Treated Patients with Psoriatic Arthritis Achieved Clinically Meaningful Improvements in General Health Outcomes Measured with PROMIS-29 Through 52 Weeks: Results from the Phase 3 Discover-1 Trial. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Coates, LC, Birt, J, Kronbergs, A et al. (4 more authors) (2021) Quality of life improvements in patients with PsA who achieve remission or low disease activity targets: results from two clinical trials of ixekizumab at three years of treatment. In: British Society for Rheumatology Annual Conference 2021, 26-28 Apr 2021, Virtual.

Coates, LC, Garrood, T, Gullick, N et al. (8 more authors) (2021) Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC. In: British Society for Rheumatology Annual Conference 2021, 26-28 Apr 2021, Virtual.

Coates, LC, Ritchlin, CT, Gossec, L et al. (12 more authors) (2021) Guselkumab Provides Domain-Specific and Comprehensive Efficacy as Assessed using Composite Endpoints in Patients with Active Psoriatic Arthritis. In: Twelfth International Congress on Spondyloarthritides, 09-11 Sep 2021, Virtual.

Coates, LC, Gladman, DD, Van den Bosch, F et al. (10 more authors) (2021) Long-Term Outcomes with Filgotinib, an Oral Preferential Janus Kinase 1 Inhibitor: 100-Week Data from an Open-Label Extension (OLE) Study in Patients with PSA. In: Twelfth International Congress on Spondyloarthritides, 09-11 Sep 2021, Virtual.

Kavanaugh, A, Helliwell, P orcid.org/0000-0002-4155-9105, Sesin, C et al. (6 more authors) (2021) Low Disease Thresholds up to Three Years in Ixekizumab-Treated Patients with Psoriatic Arthritis in SPIRIT-P1 and SPIRIT-P2. In: Twelfth International Congress on Spondyloarthritides, 09-11 Sep 2021, Virtual.

Orbai, AM, Coates, LC, Deodhar, A et al. (8 more authors) (2020) AB0813 GUSELKUMAB-TREATED PATIENTS ACHIEVED CLINICALLY MEANINGFUL IMPROVEMENT IN SYSTEMIC SYMPTOMS AS MEASURED WITH PROMIS INSTRUMENT: RESULTS FROM PHASE-3 PSORIATIC ARTHRITIS TRIAL DISCOVER 1. In: EULAR 2020, 03-06 Jun 2020, Online.

Poddubnyy, D, Mease, PJ, Van den Bosch, F et al. (9 more authors) (2020) AB0824 WHICH PARAMETERS ARE RELEVANT IN THE IDENTIFYING AXIAL INVOLVEMENT IN PSORIATIC ARTHRITIS? – RESULTS OF A SURVEY AMONG ASAS AND GRAPPA MEMBERS. In: EULAR 2020, 03-06 Jun 2020, Online.

Tillett, W, Helliwell, P, Fitzgerald, O et al. (13 more authors) (2020) AB0839 RELIABILITY OF COMPOSITE MEASURES FOR THE ASSESSMENT OF PSORIATIC ARTHRITIS. In: EULAR 2020, 03-06 Jun 2020, Online.

Helliwell, P, Tillett, W, Waxman, R et al. (4 more authors) (2020) AB1241 EVALUATION OF A PATIENT COMPLETED DISEASE FLARE QUESTIONNAIRE IN PSORIATIC DISEASE. In: EULAR 2020, 03-06 Jun 2020, Online.

Gladman, DD, Coates, LC, Van den Bosch, F et al. (9 more authors) (2020) FRI0339 LONG-TERM EFFICACY OF THE ORAL SELECTIVE JANUS KINASE 1 INHIBITOR FILGOTINIB IN PSORIATIC ARTHRITIS: WEEK 52 RESPONSE PATTERNS IN INDIVIDUAL PATIENTS FROM AN OPEN-LABEL EXTENSION (OLE) STUDY (EQUATOR2). In: EULAR 2020, 03-06 Jun 2020, Online.

Helliwell, P, Van den Bosch, F, Coates, LC et al. (9 more authors) (2020) FRI0343 EFFICACY AND SAFETY OF FILGOTINIB, A SELECTIVE JANUS KINASE 1 INHIBITOR, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: SUBGROUP ANALYSES FROM A RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 TRIAL (EQUATOR). In: EULAR 2020, 03-06 Jun 2020, Online.

Ogdie, A, Weinstein, S, Coates, LC et al. (2 more authors) (2020) SAT0433 TRIAL SIMULATION TO INFORM ENROLLMENT CRITERIA AND OUTCOME MEASURES FOR PRAGMATIC TRIALS IN PsA. In: EULAR 2020, 03-06 Jun 2020, Online.

Ovseiko, PV, Gossec, L, Andreoli, L et al. (21 more authors) (2020) THU0580: EULAR Task Force on Gender Equity in Academic Rheumatology: Preliminary Survey Findings. In: European League Against Rheumatism (EULAR) 2020, 03-06 Jun 2020, Online.

Helliwell, P, Coates, LC, FitzGerald, O et al. (8 more authors) (2018) Tofacitinib Improves Composite Endpoint Measures of Disease in Patients with Psoriatic Arthritis. In: Pan-American League of Rheumatology Associations (PANLAR) Congress 2018, 07-10 Apr 2018, Buenos Aires, Argentina.

Proceedings Paper

De Marco, G, Berekméri, A, Coates, LC et al. (10 more authors) (2019) Non Topical Pharmacological Treatment of Early, Untreated (DMARD-Naive, Systematic Therapy-Naive) Psoriatic Disease: a Systematic Review. In: Annals of the Rheumatic Diseases. EULAR 2019: Annual European Congress of Rheumatology, 12-15 Jun 2019, Madrid, Spain. BMJ Publishing Group , p. 904.

Merola, JF, Coates, LC, Husni, ME et al. (3 more authors) (2018) Ixekizumab reduces disease activity up to 52 weeks in active psoriatic arthritis patients with inadequate response to tumor necrosis factor inhibitors: An assessment with the use of minimal disease activity scores. In: Journal of the American Academy of Dermatology. American Academy of Dermatology 2018 Annual Meeting, 16-20 Feb 2018, San Diego, California, USA. Elsevier , AB174-AB174.

Duarte-Garcia, A, Eder, L, Stephens-Shields, A et al. (13 more authors) (2018) Construct Validity of the Swollen and Tender Joint Counts for the Measurement of MSK Disease Activity in Psoriatic Arthritis. In: Arthritis and Rheumatology. 2018 ACR/ARHP Annual Meeting, 19-24 Oct 2018, Chicago, IL, USA. Wiley .

Mease, PJ, Gladman, DD, van den Bosch, F et al. (10 more authors) (2018) Filgotinib, an Oral, Selective Janus Kinase 1 Inhibitor, Is Effective in Psoriatic Arthritis Patients with an Inadequate Response to Conventional Disease-Modifying Anti-Rheumatic Drugs: Results from a Randomized, Placebo-Controlled, Phase 2 Study. In: Arthritis and Rheumatology. 2018 ACR/ARHP Annual Meeting, 19-24 Oct 2018, Chicago, IL, USA. Wiley .

Gromer, D, Coates, LC, FitzGerald, O et al. (3 more authors) (2018) Identification of Treatment Naïve Patients with Psoriatic Arthritis Who Will Require a TNF Inhibitor. In: Arthritis and Rheumatology. 2018 ACR/ARHP Annual Meeting, 19-24 Oct 2018, Chicago, IL, USA. Wiley .

Freeston, JE orcid.org/0000-0003-0358-338X, Coates, LC orcid.org/0000-0002-4756-663X, Helliwell, PS et al. (4 more authors) (2010) Is There Sub-Clinical Joint Disease in Early Psoriatic Arthritis? A Clinical Comparison with Power Doppler Ultrasound. In: Rheumatology. Annual Meeting of the British Society of Rheumatology, 21-23 Apr 2010, Birmingham, UK. Oxford University Press .

This list was generated on Sat Mar 23 11:45:30 2024 GMT.